Document is current
Any future updates will be listed below
-
Authors
Lee, David S. M. https://orcid.org/0000-0002-8821-9028
Park, Joseph https://orcid.org/0000-0002-3313-641X
Kromer, Andrew
Baras, Aris https://orcid.org/0000-0002-6830-3396
Rader, Daniel J. https://orcid.org/0000-0002-9245-9876
Ritchie, Marylyn D. https://orcid.org/0000-0002-1208-1720
Ghanem, Louis R.
Barash, Yoseph https://orcid.org/0000-0003-3005-5048
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (GM128096)
- License Information
-
More Information
Article History
Received: 16 July 2020
Accepted: 12 February 2021
First Online: 9 March 2021
Competing interests
: A.B. is employed by Regeneron Pharmaceuticals. L.R.G. is employed by Janssen Research and Development. The rest of the authors declare no competing interests.
